Describe the strategy involved in developing a clinically useful drug from a bioactive microbial extract, making clear the different stages involved

Assignment Brief

MEDICINAL CHEMISTRY OF NATURAL PRODUCTS Essay question Describe the strategy involved in developing a clinically useful drug from a bioactive microbial extract, making clear the different stages involved, and providing some details of how each stage is conducted and the chemical and biological principles that must be considered. In your essay, where appropriate: • Use flowcharts or diagrams • Give named examples

Sample Answer

Medicinal Chemistry of Natural Products
Essay: Developing a Clinically Useful Drug from a Bioactive Microbial Extract

Developing a drug from a bioactive microbial extract involves a detailed, multi-stage process that integrates biology, chemistry, and pharmacology. This essay explains each stage, highlighting the scientific principles involved and using real examples to clarify the process.

1. Discovery and Collection

The first step is to isolate microorganisms from natural environments like soil, marine sources, or plants. These microbes may produce secondary metabolites, molecules not essential for survival but often with biological activity.

For example, Streptomyces species from soil have produced many antibiotics like streptomycin and chloramphenicol.

Principle involved: Biodiversity leads to chemical diversity. Unique environments may yield novel bioactive compounds.

2. Extraction and Screening

Microbial cultures are grown under lab conditions. Their metabolites are then extracted using solvents (e.g. methanol, ethyl acetate).

These extracts are screened using biological assays to detect useful activities such as:

• Antibacterial

• Antifungal

• Cytotoxic (cancer-related)

• Anti-inflammatory

Example: Penicillin was discovered by Alexander Fleming when Penicillium notatum showed antibacterial activity.

 3. Isolation and Structure Elucidation

Once a promising extract is found, bioassay-guided fractionation is used. This involves separating the extract into fractions using chromatography (e.g. HPLC, TLC) and testing each fraction for activity.

The active compound is then identified using spectroscopic techniques:

• NMR (Nuclear Magnetic Resonance)

• MS (Mass Spectrometry)

• IR (Infrared Spectroscopy)

Example: The anti-cancer compound doxorubicin was isolated from Streptomyces peucetius using these techniques.

4. Optimisation of the Lead Compound

The identified compound may not be ideal for clinical use. Medicinal chemists then modify its structure to improve:

• Potency

• Selectivity

• Solubility

• Stability

• Toxicity profile

This is known as lead optimisation and involves designing and testing derivatives of the original molecule.

Example: Semi-synthetic derivatives of erythromycin (like azithromycin) were developed to improve acid stability and oral bioavailability.

5. Preclinical Testing

Modified compounds go through in vitro (cell cultures) and in vivo (animal models) testing to evaluate:

• Pharmacodynamics: how the drug affects the body

• Pharmacokinetics: absorption, distribution, metabolism, excretion (ADME)

• Toxicity: acute and chronic toxicity studies

Only compounds that show safety and efficacy move forward.

6. Clinical Trials

There are three main phases of human trials:

• Phase I: Tests safety and dosage in healthy volunteers

• Phase II: Assesses effectiveness and side effects in patients

• Phase III: Large-scale trials to confirm effectiveness and monitor adverse reactions

If successful, the drug can be approved by regulatory agencies like the FDA (USA) or MHRA (UK).

Example: The antibiotic rifampicin, isolated from Streptomyces rifamycinica, passed clinical trials and became essential in tuberculosis treatment.

Continued...